Legend Biotech Corporation American Depositary Shares

Legend Biotech Corporation is a global biotechnology company primarily focused on the discovery and development of innovative cellular therapies. Its primary function centers around utilizing cutting-edge technology to harness the power of cell therapies for treating various forms of cancer. Legend Biotech operates within the medical and healthcare sectors, with particular emphasis on hematological oncology. One of the company's most significant contributions is its work on chimeric antigen receptor T-cell (CAR-T) therapy, which has shown promise in treating certain blood cancers. Through strategic partnerships and research collaborations, Legend Biotech aims to advance the field of oncology therapeutics, addressing unmet medical needs and contributing to the evolution of personalized medicine. Its innovative approach and technology-driven solutions make it an influential player in the growing biopharmaceutical landscape, impacting both healthcare advancements and the broader scientific community dedicated to combating cancer.